Ocugen (OCGN)

Ocugen on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances).

Download CSV

102.1M

Short interest

settlement 2026-09-30

13.7

Days to cover

+3.3 days vs prior

64.6%

Short share of volume

2026-10-22

15,066

Fails to deliver

settlement 2026-09-28

Wed 4 Nov

Next earnings

estimated date

-$1.1M

Insider flow, 90 days

0 buys, 4 sells

As of 2026-10-22.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 30 September 2026, short interest in OCGN is 102,053,118 shares, up 3,743,697 shares over the last month. Over the last 48 readings it ranged from 46,392,427 shares (31 December 2025) to 106,062,298 shares (15 September 2026). The latest reading sits at the top of that range. At the reported average volume of 7.5M shares a day that is 13.7 days to cover.

Embed this chart.The embed keeps its attribution line.

<iframe src="https://xoomar.com/embed/stocks/ocgn" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-09-30	102,053,118	-3.8%	7,472,502	13.66
2026-09-15	106,062,298	+7.9%	10,210,180	10.39
2026-08-31	98,309,421	-3.4%	3,481,659	28.24
2026-08-14	101,770,376	+0.8%	4,259,155	23.89
2026-07-31	100,913,607	+0.3%	4,681,821	21.55
2026-07-15	100,590,405	-4.6%	5,336,703	18.85
2026-06-30	105,430,735	+21.8%	14,922,590	7.07
2026-06-15	86,561,503	+4.3%	4,682,762	18.49
2026-05-29	83,020,405	+2.4%	5,795,786	14.32
2026-05-15	81,047,338	+16.3%	9,926,269	8.16
2026-04-30	69,673,506	+2.6%	6,025,350	11.56
2026-04-15	67,890,507	+4.8%	5,464,214	12.42
2026-03-31	64,754,908	+23.7%	12,231,366	5.29
2026-03-13	52,358,943	+3.5%	12,529,657	4.18
2026-02-27	50,589,268	+3.1%	5,092,688	9.93
2026-02-13	49,061,740	+3.8%	3,278,829	14.96
2026-01-30	47,284,982	-1.3%	5,568,175	8.49
2026-01-15	47,899,156	+3.3%	7,161,244	6.69
2025-12-31	46,392,427	-21.4%	4,081,573	11.37
2025-12-15	58,994,853	-0.8%	3,441,567	17.14
2025-11-28	59,490,622	+0.7%	2,896,735	20.54
2025-11-14	59,091,529	+1.9%	3,786,072	15.61
2025-10-31	58,010,350	-0.2%	3,292,607	17.62
2025-10-15	58,104,492	+10.1%	7,695,059	7.55
2025-09-30	52,777,098	-2.4%	8,436,965	6.26
2025-09-15	54,084,578	-0.8%	2,509,147	21.55
2025-08-29	54,538,456	-1.2%	1,816,788	30.02
2025-08-15	55,215,639	+0.8%	2,449,036	22.55
2025-07-31	54,761,058	-2.4%	3,142,564	17.43
2025-07-15	56,127,276	-11.2%	4,361,217	12.87
2025-06-30	63,212,833	-3.0%	11,383,283	5.55
2025-06-13	65,193,477	-4.8%	5,836,707	11.17
2025-05-30	68,472,892	-1.6%	6,378,706	10.73
2025-05-15	69,595,032	+2.0%	3,165,479	21.99
2025-04-30	68,225,493	-0.6%	2,869,845	23.77
2025-04-15	68,666,964	+4.4%	4,078,269	16.84
2025-03-31	65,794,489	-2.5%	4,353,120	15.11
2025-03-14	67,513,578	+6.0%	4,121,595	16.38
2025-02-28	63,673,877	+5.7%	3,558,729	17.89
2025-02-14	60,259,171	+2.3%	3,451,689	17.46
2025-01-31	58,883,625	+4.9%	3,836,819	15.35
2025-01-15	56,110,366	+7.4%	5,523,724	10.16
2024-12-31	52,258,018	-10.9%	6,914,651	7.56
2024-12-13	58,632,954	+2.9%	3,880,925	15.11
2024-11-29	56,995,210	+4.8%	3,721,866	15.31
2024-11-15	54,396,876	+7.4%	4,342,461	12.53
2024-10-31	50,645,227	-2.5%	3,131,871	16.17
2024-10-15	51,917,995	+2.6%	2,860,377	18.15

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 22 October 2026, the short share of OCGN volume is 64.6%, up 1.9 points over the last five sessions. Over the last 30 readings it ranged from 47.8% (29 September 2026) to 77.2% (30 September 2026). The latest reading is in line with the 30-session average of 65.9%, on 4.5M shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-10-22	2.9M	4.5M	64.6%	2,500
2026-10-21	2.0M	2.6M	77.0%	5,271
2026-10-20	2.9M	4.3M	68.4%	38,318
2026-10-19	1.5M	2.6M	57.4%	3,974
2026-10-16	2.0M	3.0M	65.6%	0
2026-10-15	1.9M	3.1M	62.8%	203,540
2026-10-14	3.6M	5.4M	67.1%	190,550
2026-10-13	3.0M	4.1M	74.7%	2,922
2026-10-12	1.2M	1.9M	65.5%	2,500
2026-10-09	6.3M	8.6M	73.3%	23,914
2026-10-08	4.3M	5.8M	73.0%	12,747
2026-10-07	2.2M	3.4M	64.1%	3,386
2026-10-06	1.3M	2.6M	49.1%	1,271
2026-10-05	1.9M	3.0M	64.0%	2,888
2026-10-02	972K	1.4M	69.7%	18,352
2026-10-01	1.4M	2.3M	61.7%	225
2026-09-30	2.7M	3.5M	77.2%	3,437
2026-09-29	2.0M	4.2M	47.8%	2,099
2026-09-28	1.9M	2.7M	70.7%	151
2026-09-25	2.7M	4.7M	57.9%	997
2026-09-24	2.2M	3.2M	69.7%	10,596
2026-09-23	5.4M	7.0M	76.9%	2,922
2026-09-22	2.1M	3.2M	67.1%	11,200
2026-09-21	1.4M	2.4M	60.8%	11,795
2026-09-18	1.9M	3.3M	57.0%	13,438
2026-09-17	1.3M	2.1M	61.8%	1,288
2026-09-16	4.0M	6.1M	65.5%	25,218
2026-09-15	6.0M	8.8M	67.6%	15,101
2026-09-14	2.4M	3.7M	65.5%	0
2026-09-11	2.2M	3.1M	72.0%	5,302

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 28 September 2026, the fails-to-deliver balance in OCGN is 15,066 shares, up 13,026 shares over the last settlement date. Over the last 30 readings it ranged from 65 shares (4 September 2026) to 381,853 shares (6 August 2026). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-09-28	15,066	$1.02	$15K
2026-09-22	2,040	$1.03	$2K
2026-09-18	17,102	$1.03	$18K
2026-09-10	140,358	$1.07	$150K
2026-09-09	21,762	$1.33	$29K
2026-09-08	58,592	$1.36	$80K
2026-09-04	65	$1.35	$88
2026-09-03	134,336	$1.32	$177K
2026-09-02	99,231	$1.33	$132K
2026-08-28	440	$1.37	$603
2026-08-27	3,244	$1.41	$5K
2026-08-26	455	$1.40	$637
2026-08-25	50,006	$1.36	$68K
2026-08-24	801	$1.39	$1K
2026-08-21	20,574	$1.39	$29K
2026-08-20	14,240	$1.48	$21K
2026-08-19	495	$1.34	$663
2026-08-17	19,692	$1.35	$27K
2026-08-13	2,858	$1.40	$4K
2026-08-10	150	$1.28	$192
2026-08-07	23,711	$1.24	$29K
2026-08-06	381,853	$1.28	$489K
2026-08-05	242	$1.31	$317
2026-08-04	97,909	$1.25	$122K
2026-07-30	37,034	$1.19	$44K
2026-07-29	104,570	$1.24	$130K
2026-07-28	743	$1.26	$936
2026-07-24	1,547	$1.27	$2K
2026-07-23	1,446	$1.29	$2K
2026-07-21	1,188	$1.33	$2K

Insider trades

SEC Form 4, newest first. JSON

Insiders at OCGN reported 4 open-market sells worth $1.1M in the last 90 days and no open-market buys. Latest filing: Musunuri Shankar (Chief Executive Officer) on 2026-10-09.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-10-09	Musunuri Shankar	Chief Executive Officer	Sell	57K	$0.95	$54K	1.0M
2026-10-09	Musunuri Shankar	Chief Executive Officer	Sell	469K	$0.95	$445K	4.0M
2026-09-09	Musunuri Shankar	Chief Executive Officer	Sell	57K	$1.12	$64K	1.1M
2026-09-09	Musunuri Shankar	Chief Executive Officer	Sell	469K	$1.12	$525K	4.5M
2026-06-15	Johnson-Greene Treerita Essalima	Chief Financial Officer	Buy	21K	$1.23	$26K	521K
2026-04-01	Zhang Junge	Director	Exercise or conversion	67K	$1.42	$95K	1.4M
2026-04-01	Zhang Junge	Director	Exercise or conversion	112K	$0.46	$52K	1.3M
2026-04-01	Zhang Junge	Director	Exercise or conversion	15K	$0.51	$8K	1.2M
2026-01-02	Ramachandran Ramesh	Chief Accounting Officer	Grant	207K	$0.00	$0	209K
2026-01-02	Musunuri Shankar	Chief Executive Officer	Grant	3.1M	$0.00	$0	5.0M
2025-01-03	Musunuri Shankar	Chief Executive Officer	Tax withholding	177K	$0.89	$158K	1.8M
2025-01-03	Upadhyay Arun	See Remarks	Tax withholding	42K	$0.89	$37K	306K
2024-11-26	Fernandes Prabhavathi	Director	Buy	10K	$0.91	$9K	10K
2024-11-22	Castillo Kirsten	Director	Buy	25K	$0.91	$23K	75K
2024-09-16	Upadhyay Arun	See Remarks	Tax withholding	842	$1.17	$985	348K
2024-06-17	Upadhyay Arun	See Remarks	Tax withholding	917	$1.42	$1K	349K
2024-01-03	Upadhyay Arun	See Remarks	Tax withholding	42K	$0.65	$27K	350K
2024-01-03	Musunuri Shankar	Chief Executive Officer	Tax withholding	180K	$0.65	$117K	2.0M
2023-09-16	Upadhyay Arun	See Remarks	Tax withholding	842	$0.41	$345	391K
2023-06-16	Upadhyay Arun	Chief Scientific Officer	Tax withholding	917	$0.51	$468	392K
2023-06-14	Zhang Junge	Director	Buy	200K	$0.50	$100K	1.1M
2023-02-16	Musunuri Shankar	Chief Executive Officer	Sell	100K	$1.08	$108K	2.2M
2023-02-16	Musunuri Shankar	Chief Executive Officer	Exercise or conversion	100K	$0.33	$33K	2.3M
2023-01-17	Musunuri Shankar	Chief Executive Officer	Exercise or conversion	100K	$0.51	$51K	2.3M
2023-01-17	Musunuri Shankar	Chief Executive Officer	Sell	100K	$1.28	$128K	2.2M
2023-01-03	Musunuri Shankar	Chief Executive Officer	Grant	1.5M	$0.00	$0	2.2M
2023-01-03	Crespo Jessica	CAO/SVP, Finance	Grant	123K	$0.00	$0	163K
2023-01-03	Upadhyay Arun	Chief Scientific Officer	Grant	316K	$0.00	$0	400K
2023-01-03	Musunuri Shankar	Chief Executive Officer	Tax withholding	38K	$1.25	$47K	2.2M
2023-01-03	Crespo Jessica	CAO/SVP, Finance	Tax withholding	2K	$1.25	$2K	161K
2023-01-03	Upadhyay Arun	Chief Scientific Officer	Tax withholding	7K	$1.25	$9K	393K
2022-12-16	Musunuri Shankar	Chief Executive Officer	Exercise or conversion	96K	$0.51	$49K	848K
2022-12-16	Musunuri Shankar	Chief Executive Officer	Sell	96K	$1.43	$137K	753K
2022-10-14	Musunuri Shankar	Chief Executive Officer	Sell	100K	$1.66	$166K	753K
2022-10-14	Musunuri Shankar	Chief Executive Officer	Exercise or conversion	100K	$0.51	$51K	853K
2022-10-06	Kumar Ramesh	Director	Sell	5K	$1.83	$8K	0
2022-10-06	Kumar Ramesh	Director	Exercise or conversion	5K	$0.51	$2K	5K
2022-08-11	Castillo Kirsten	Director	Exercise or conversion	42K	$0.28	$12K	92K
2022-08-11	Castillo Kirsten	Director	Sell	42K	$2.91	$122K	50K
2022-07-18	Kumar Ramesh	Director	Exercise or conversion	8K	$0.51	$4K	8K
2022-07-18	Kumar Ramesh	Director	Sell	8K	$2.57	$19K	0
2022-07-14	Musunuri Shankar	Chief Executive Officer	Sell	150K	$2.72	$408K	753K
2022-07-14	Musunuri Shankar	Chief Executive Officer	Exercise or conversion	150K	$0.33	$50K	903K
2022-05-13	Musunuri Shankar	Chief Executive Officer	Sell	125K	$1.92	$240K	753K
2022-05-13	Musunuri Shankar	Chief Executive Officer	Exercise or conversion	125K	$0.33	$41K	878K
2022-04-18	Kumar Ramesh	Director	Sell	8K	$2.83	$21K	0
2022-04-18	Kumar Ramesh	Director	Exercise or conversion	8K	$0.51	$4K	8K
2022-03-18	Crespo Jessica	CAO/SVP, Finance	Grant	23K	$0.00	$0	40K
2022-03-16	Musunuri Shankar	Chief Executive Officer	Exercise or conversion	82K	$0.33	$27K	834K
2022-03-16	Musunuri Shankar	Chief Executive Officer	Sell	82K	$2.65	$217K	753K
2022-03-03	Zhang Junge	Director	Exercise or conversion	39K	$0.51	$20K	39K
2022-03-03	Zhang Junge	Director	Exercise or conversion	49K	$1.83	$90K	88K
2022-02-14	Musunuri Shankar	Chief Executive Officer	Sell	90K	$3.74	$337K	753K
2022-02-14	Musunuri Shankar	Chief Executive Officer	Exercise or conversion	90K	$0.33	$30K	843K
2022-01-18	Kumar Ramesh	Director	Exercise or conversion	8K	$0.51	$4K	8K
2022-01-18	Kumar Ramesh	Director	Sell	8K	$4.07	$31K	0
2022-01-03	Musunuri Shankar	Chief Executive Officer	Grant	347K	$0.00	$0	753K
2022-01-03	Subramanian Sanjay	Chief Financial Officer	Grant	126K	$0.00	$0	161K
2021-12-16	Musunuri Shankar	Chief Executive Officer	Sell	115K	$5.22	$600K	1.1M
2021-12-16	Potti Manish	Director	Exercise or conversion	32K	$1.83	$58K	45K
2021-12-16	Potti Manish	Director	Exercise or conversion	14K	$0.51	$7K	14K
2021-11-16	Musunuri Shankar	Chief Executive Officer	Sell	115K	$8.04	$925K	1.3M
2021-11-16	Zhang Junge	Director	Exercise (in or at the money)	2K	$7.56	$12K	877K
2021-11-16	Zhang Junge	Director	Exercise (in or at the money)	144K	$2.77	$398K	875K
2021-11-03	Zhang Junge	Director	Sell	150K	$17.32	$2.6M	731K
2021-11-02	Zhang Junge	Director	Sell	150K	$15.75	$2.4M	882K
2021-11-02	Castillo Kirsten	Director	Sell	15K	$15.00	$225K	50K
2021-11-02	Potti Manish	Director	Sell	63K	$15.07	$956K	28K
2021-11-02	Kompella Uday	Director	Sell	25K	$16.01	$400K	154K
2021-11-01	Musunuri Shankar	Chief Executive Officer	Exercise or conversion	115K	$0.51	$59K	521K
2021-11-01	Musunuri Shankar	Chief Executive Officer	Sell	115K	$14.15	$1.6M	406K
2021-11-01	Kompella Uday	Director	Sell	25K	$14.05	$351K	179K
2021-10-26	Kompella Uday	Director	Sell	25K	$12.05	$301K	204K
2021-10-26	Subramanian Sanjay	Chief Financial Officer	Sell	10K	$11.07	$111K	36K
2021-10-25	Kompella Uday	Director	Sell	46K	$9.08	$421K	229K
2021-10-21	Kompella Uday	Director	Sell	2K	$9.01	$17K	276K
2021-10-20	Kompella Uday	Director	Sell	2K	$9.02	$16K	278K
2021-10-18	Kumar Ramesh	Director	Sell	8K	$8.13	$61K	0
2021-10-18	Kumar Ramesh	Director	Exercise or conversion	8K	$0.51	$4K	8K
2021-10-18	Kompella Uday	Director	Sell	200K	$8.41	$1.7M	279K
2021-10-15	Subramanian Sanjay	Chief Financial Officer	Sell	8K	$9.96	$80K	46K
2021-10-15	Subramanian Sanjay	Chief Financial Officer	Exercise or conversion	8K	$2.19	$17K	54K
2021-10-15	Musunuri Shankar	Chief Executive Officer	Sell	125K	$9.80	$1.2M	406K
2021-10-15	Musunuri Shankar	Chief Executive Officer	Exercise or conversion	125K	$0.33	$41K	531K
2021-09-15	Musunuri Shankar	Chief Executive Officer	Exercise or conversion	125K	$0.33	$41K	531K
2021-09-15	Musunuri Shankar	Chief Executive Officer	Sell	125K	$7.52	$940K	406K
2021-08-16	Subramanian Sanjay	Chief Financial Officer	Sell	30K	$7.22	$217K	46K
2021-08-16	Subramanian Sanjay	Chief Financial Officer	Exercise or conversion	30K	$0.34	$10K	76K
2021-07-30	Kompella Uday	Director	Exercise or conversion	10K	$1.83	$18K	561K
2021-07-30	Kompella Uday	Director	Sell	10K	$6.81	$68K	551K
2021-07-19	Kumar Ramesh	Director	Exercise or conversion	8K	$0.51	$4K	8K
2021-07-19	Kumar Ramesh	Director	Sell	8K	$6.40	$48K	0
2021-07-15	Subramanian Sanjay	Chief Financial Officer	Sell	31K	$6.70	$208K	46K
2021-07-15	Subramanian Sanjay	Chief Financial Officer	Exercise or conversion	31K	$0.34	$11K	77K
2021-06-25	Kompella Uday	Director	Exercise or conversion	10K	$1.83	$18K	561K
2021-06-25	Kompella Uday	Director	Sell	10K	$8.13	$81K	551K
2021-06-15	Potti Manish	Director	Exercise (in or at the money)	96K	$6.30	$604K	159K
2021-06-15	Potti Manish	Director	Sell	68K	$8.86	$604K	91K
2021-06-15	Subramanian Sanjay	Chief Financial Officer	Sell	31K	$7.00	$217K	46K
2021-06-15	Subramanian Sanjay	Chief Financial Officer	Exercise or conversion	31K	$0.34	$11K	77K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

6 holders report 5% or more of OCGN in their latest filing, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 8.0% of the class (26,952,492 shares), filed 2026-07-29 for an event on 2026-06-30.

Filed	Form	Holder	Shares	Of class	Event
2026-08-13	13G/Ano. 1	JANUS HENDERSON GROUP Ltd.parent holding company	10.0M	3.0%	2026-06-30
2026-08-07	13G	STATE STREET CORPORATIONparent holding company	21.5M	6.3%	2026-06-30
2026-07-29	13G	BlackRock, Inc.parent holding company	27.0M	8.0%	2026-06-30
2026-04-14	13G	Millennium Management LLCother entity	17.1M	5.2%	2026-04-09
2026-04-14	13G	Millennium Group Management LLCother entity	17.1M	5.2%	2026-04-09
2026-04-14	13G	Israel A. Englanderindividual	17.1M	5.2%	2026-04-09
2026-03-27	13G/Ano. 1	The Vanguard Groupinvestment adviser	0	0.0%	2026-03-13
2025-12-08	13G	JANUS HENDERSON GROUP PLCinvestment adviser, parent holding company	20.0M	6.0%	2025-11-28

13F holders

Tracked managers holding OCGN at their latest 13F. JSON

4 of the 30 tracked managers held OCGN at their latest 13F, $26.7M in total at quarter-end prices. Millennium Management is the largest at $21.3M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 3 cut.

Fund	Quarter	Shares	Value	Of portfolio	Change in shares
Millennium Management	2026-06-30	13.9M	$21.3M	0.01%	+216K
Two Sigma Investments	2026-06-30	2.2M	$3.4M	0.00%	-21K
Citadel Advisors	2026-06-30	783K	$1.2M	0.00%	-2.0M
Point72 Asset Management	2026-06-30	478K	$731K	0.00%	-357K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Ocugen in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Ocugen (OCGN), SEC CIK 1372299, listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances). The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest: FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-22.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-28.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-13.JSON and CSV
13F holders: SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates: SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-06.JSON and CSV
Insider trades: SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-09.JSON and CSV
Company record: EDGAR filing index for CIK 1372299Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 10 requests a minute without a key, 30 with a free key from a free account.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other companies the SEC classifies as biological products, (no diagnostic substances)

Other company pages

Datasets

Frequently Asked Questions

How much of OCGN is sold short?

102,053,118 shares were held short at the 2026-09-30 settlement, 13.7 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is OCGN's daily short volume?

On 2026-10-22, 2,885,084 of the 4,463,648 OCGN shares reported to FINRA were sold short, 64.6% of the day's reported volume. Short volume is a flow for one day, not a position.

Does OCGN have fails to deliver?

The SEC's latest file shows 15,066 OCGN shares failed to deliver at settlement 2026-09-28. Fails are reported per settlement date and published twice a month with a lag.

Are OCGN insiders buying or selling?

Insiders at OCGN reported 4 open-market sells worth $1.1M in the last 90 days and no open-market buys. Latest filing: Musunuri Shankar (Chief Executive Officer) on 2026-10-09.

Who owns 5% or more of OCGN?

Which tracked 13F managers own OCGN?

4 of the 30 tracked 13F managers held OCGN shares at their latest filing, $26.7M in all. The largest: Izzy Englander's Millennium Management (13.9M shares, $21.3M), Two Sigma Investments (2.2M shares, $3.4M), Ken Griffin's Citadel Advisors (783K shares, $1.2M), Steve Cohen's Point72 Asset Management (478K shares, $731K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.